Patents by Inventor Jung-whan LEE

Jung-whan LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240194179
    Abstract: The present invention relates to a method and an apparatus for synthesizing the voice based on brain waves during imagined speech. The method for synthesizing the voice based on brain waves during imagined speech according to an embodiment of the present invention may include the following steps: a step to obtain the user's brain waves during imagined speech; a step to convert the above-mentioned brain waves of imagined speech into embedding vectors; a step to generate the mel-spectrograms based on the above-mentioned embedding vectors; a step to generate the voice using the above-mentioned mel-spectrograms; a step to output the above-mentioned voice.
    Type: Application
    Filed: May 19, 2023
    Publication date: June 13, 2024
    Applicant: Korea University Research and Business Foundation
    Inventors: Seong Whan LEE, Young Eun LEE, Seo Hyun LEE, Soo Won KIM, Sang Ho KIM, Byung Kwan KO, Ji Won LEE, Jung Sun LEE
  • Publication number: 20240176421
    Abstract: Disclosed is an apparatus for performance improvement in multimodal communication according to one embodiment of the present invention.
    Type: Application
    Filed: November 30, 2023
    Publication date: May 30, 2024
    Inventors: Seong Whan LEE, Ji Won LEE, Seo Hyun LEE, Soowon KIM, Jung Sun LEE
  • Patent number: 11932618
    Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.
    Type: Grant
    Filed: March 13, 2023
    Date of Patent: March 19, 2024
    Assignee: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Hong Chul Yoon, Kyung Mi An, Myong Jae Lee, Jin Hee Lee, Jeong-geun Kim, A-rang Im, Woo Jin Jeon, Jin Ah Jeong, Jaeho Heo, Changhee Hong, Kyeojin Kim, Jung-Eun Park, Te-ik Sohn, Changmok Oh, Da Hae Hong, Sung Wook Kwon, Jung Ho Kim, Jae Eui Shin, Yeongran Yoo, Min Whan Chang, Eun Hye Jang, In-gyu Je, Ji Hye Choi, Gunhee Kim, Yearin Jun
  • Publication number: 20190252100
    Abstract: The present invention provides a ferrite magnetic material that is inexpensive by reducing the contents of La and Co and capable of providing a remarkably high maximum energy product ((BH)max) as compared with the conventional ferrite magnetic materials by inducing a high saturation magnetization and a high anisotropic magnetic field.
    Type: Application
    Filed: June 7, 2017
    Publication date: August 15, 2019
    Inventors: Minho KIM, Dongyoung LEE, Jung-whan LEE, Eunseon CHEONG